Work

Abstract P1-07-09: A multi-OMIC analysis to explore the impact of “actionable” genomic alterations on protein pathway activation: Clinical implication for precision medicine in metastatic breast cancer

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs16-p1-07-09

Authors: M Pierobon, S Wong, A Reeded, S Anthony, N Robert, DW Northfelt, M Jahanzeb, L Vocila, J Wulfkuhle, B Dunetz, J Aldrich, S Byron, D Craig, L Liotta, J Carpten, EF Petricoin

Institutions: University of Southern California, Translational Genomics Research Institute, University of Miami, George Mason University, Side-Out Foundation, Virginia Cancer Specialists, Mayo Clinic in Arizona, Arizona Oncology, Translational Drug Development (United States)

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592567345

Cites:

Cited by:

Related to: 10